Brian C. Stephenson, Secretary, Treasurer & CFO at BridgeBio Pharma, Inc. (BBIO), sold 68,000 shares at $36.29 ($2.5M) on 2025-01-28, disclosed to the SEC on 2025-01-30.
Scheduled sale ($2.5M) by Secretary, Treasurer & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FTH | BUY | 2026-06-24 | $406K | — | Filing → |
| BBIO | SELL | 2025-02-27 | $282K | — | Filing → |
| BBIO | SELL | 2025-02-19 | $300K | — | Filing → |